AstraZeneca's trial illnesses may not be due to Covid-19 shot
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) started an accelerated "rolling review" of the vaccine at the start of this month as data comes in on safety and efficacy. Photo: Reuters
The adverse events that led to a pause in trials evaluating AstraZeneca Plc's Covid-19 vaccine candidate may not have been associated with the vaccine itself, according to a document outlining participant information that was posted online by the Oxford University.
Keep updated, follow The Business Standard's Google news channel
